A Model for Dimerization of the SOX Group E Transcription Factor Family

Group E members of the SOX transcription factor family include SOX8, SOX9, and SOX10. Preceding the high mobility group (HMG) domain in each of these proteins is a thirty-eight amino acid region that supports the formation of dimers on promoters containing tandemly inverted sites. The purpose of thi...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 8; p. e0161432
Main Authors Ramsook, Sarah N, Ni, Joyce, Shahangian, Shokofeh, Vakiloroayaei, Ana, Khan, Naveen, Kwan, Jamie J, Donaldson, Logan W
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 17.08.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Group E members of the SOX transcription factor family include SOX8, SOX9, and SOX10. Preceding the high mobility group (HMG) domain in each of these proteins is a thirty-eight amino acid region that supports the formation of dimers on promoters containing tandemly inverted sites. The purpose of this study was to obtain new structural insights into how the dimerization region functions with the HMG domain. From a mutagenic scan of the dimerization region, the most essential amino acids of the dimerization region were clustered on the hydrophobic face of a single, predicted amphipathic helix. Consistent with our hypothesis that the dimerization region directly contacts the HMG domain, a peptide corresponding to the dimerization region bound a preassembled HMG-DNA complex. Sequence conservation among Group E members served as a basis to identify two surface exposed amino acids in the HMG domain of SOX9 that were necessary for dimerization. These data were combined to make a molecular model that places the dimerization region of one SOX9 protein onto the HMG domain of another SOX9 protein situated at the opposing site of a tandem promoter. The model provides a detailed foundation for assessing the impact of mutations on SOX Group E transcription factors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors note that one author, JN, is employed by a commercial company: Sanofi-Pasteur Pharmaceuticals. This company did not provide a salary for the author and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This commercial affiliation does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Current address: McEwen Centre for Regenerative Medicine, Ontario Cancer Institute, Toronto, ON Canada
Current address: Sanofi-Pasteur Pharmaceuticals, Toronto, ON, Canada
Conceptualization: LWD. Formal analysis: SNR JN SS. Funding acquisition: LWD. Investigation: SNR JN SS AV NK JJK LWD. Methodology: SNR JN SS AV LWD. Software: LWD. Supervision: LWD. Validation: SNR JN SS AV LWD. Visualization: SNR JN SS AV LWD. Writing - original draft: LWD. Writing - review & editing: LWD.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0161432